價(jià)格 | ¥17400 |
包裝 | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:LMIR2, Human, 重組蛋白 (hFc) | 英文名稱:LMIR2 Protein, Human, Recombinant (hFc) |
品牌: TargetMol | 產(chǎn)地: 美國(guó) |
保存條件: Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. | 產(chǎn)品類別: 抑制劑 |
貨號(hào): TMPJ-00109 |
名稱 | LMIR2 Protein, Human, Recombinant (hFc) |
描述 | CD300C is a single-pass type I membrane protein which belongs to the immunoregulatory signaling (IRS) family. CD300C contains one Ig-like V-type domain and is present on the surface of natural killer cells, granulocytes, most myeloid cells, dendritic cells, and a subpopulation of T and B lymphocytes. The CD300C (CMRF-35A) and CD300A (CMRF-35H) molecules are homologous leukocyte surface proteins. CD300a and CD300C play an important role in the cross-regulation of TNF-alpha and IFN-alpha secretion from pDCs. CD300A and CD300C are indistinguishable on the surface of NK cells. The ligand for CD300C is presently unknown. |
存儲(chǔ)條件 | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. |
關(guān)鍵字 | CMRF 35 | CLM 6 | CLM6 |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 589.8595萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
¥2460 |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-20 | |
¥220 |
VIP5年
|
匯智和源生物技術(shù)(蘇州)有限公司
|
2025-01-03 | |
¥2600 |
VIP4年
|
上海博爾森生物科技有限公司
|
2025-01-17 |